CorVel Corporation

NASDAQ:CRVL

Insurance - Brokers

Financial Services
$88.87 -0.12%

-$0.07 today

Market cap
$4.47B
Beta
0.98
P/E (TTM)
26.9
EPS (TTM)
$2.16
52W Low $44.83High $105.51

Volume 0.26M

Average 0.22M

CRVL Net Income

Bottom-line profit, the starting point for calculating cash from operations.

CorVel CorporationNASDAQ: CRVL

Net Income · Q1 FY2027 · quarter ended Jun 2026

Net income grows, but more slowly than its trailing trend

Q1 FY2027 net income of $32.23M rose 18.3% year over year, behind the +109348.2% change in trailing-twelve-month net income. Sequentially, it fell 100.0% from the prior quarter. Over 3 fiscal years it compounded at +18.5% a year.

Context

  • Net income amounted to 11.5% of revenue in FY2026, up 0.9 pp from a year earlier.
  • Net income increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +18.3% toward the trailing-twelve-month pace of +109348.2%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$32.23M-100.0% QoQ
Last fiscal yearMar 2026
$110.34M+16.0% YoY
LTMJun 2026
$110.35B+109348.2% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+18.3%——
1 year+16.0%——
3-year CAGR+18.5%——
5-year CAGR——
10-year CAGR——

Net Income history

USD · from the cash flow

Latest · FY2026
110.34M USD
Year-over-year change
+16.0%
4-year CAGR
+13.5%

Net Income vs competitors

How CRVL compares with its peers on the latest reported figures

  • CRVL's LTM Jun 2026 net income of $110.35B is the largest of the 4 companies compared; the peer median is $286.52M.
  • Its year-over-year change of +109348.2% is the highest of 4, against a peer median of +62.2%.
  • Net income amounts to 11217.3% of revenue for CRVL, versus a peer median of 27.9%.
CRVL Competitors Peer median
Net Income for CRVL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CRVLCorVel CorporationLTM Jun 2026$110.35B +109348.2%+18.5%11217.3%
EVHEvolent Health, Inc.LTM Mar 2026$527.72M +384.3%+211.5%27.9%
CTEVClaritev CorporationLTM Mar 2026$286.52M -75.7%-20.8%29.3%
HQYHealthEquity, Inc.LTM Jul 2026$236.49M +62.2%—17.4%
Peer median (excluding CRVL) $286.52M+62.2%+95.3%27.9%

Competitors are the stored peer set for CRVL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Net Income66.41M66.37M76.25M95.17M110.34M
Depreciation & Amortization23.92M25.12M26.25M29.54M31.76M
Deferred Income Tax2.3M(1.91M)(3.32M)(5.16M)4.78M
Stock-Based Compensation5.2M5.56M4.98M5.71M5.41M
Change in Working Capital(30.88M)(14.48M)(7.05M)(1.83M)2.52M
Accounts Receivables(18.02M)336K(17.9M)(10.46M)2.7M
Inventory00000
Accounts Payables0000(728K)
Other Working Capital(12.86M)(14.81M)10.86M8.63M546K
Other Non-Cash Items280K1.63M2.12M3.89M825K
Operating Cash Flow67.22M82.29M99.24M127.32M155.64M
Capital Expenditures(29.82M)(26.32M)(29.24M)(35.76M)(45.36M)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow(29.82M)(26.32M)(29.24M)(35.76M)(45.36M)
Debt Repayment00000
Common Stock Issued00008.41M
Common Stock Repurchased(90.09M)(93.68M)(45.71M)(37.61M)(56.21M)
Dividends Paid00000
Other Financing Activities10.47M11.53M9.95M11.07M0
Financing Cash Flow(79.62M)(82.14M)(35.76M)(26.54M)(47.8M)
Effect of Forex Changes00000
Net Change in Cash(42.21M)(26.18M)34.23M65.02M62.49M
Free Cash Flow37.4M55.97M70M91.56M110.28M

CorVel Corporation

NASDAQ:CRVL

Intrinsic Alpha fair value

Locked

Current Price

$88.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.